SPG21: Difference between revisions
Content deleted Content added
m →Further reading: Journal cites, Added 1 doi to a journal cite using AWB (10365) |
|||
| Line 17: | Line 17: | ||
{{PBB_Further_reading |
{{PBB_Further_reading |
||
| citations = |
| citations = |
||
*{{cite journal | author=Cross HE, McKusick VA |title=The mast syndrome. A recessively inherited form of presenile dementia with motor disturbances |journal=Arch. Neurol. |volume=16 |issue= 1 |pages= 1–13 |year= 1967 |pmid= 6024251 |doi= }} |
*{{cite journal | author=Cross HE, McKusick VA |title=The mast syndrome. A recessively inherited form of presenile dementia with motor disturbances |journal=Arch. Neurol. |volume=16 |issue= 1 |pages= 1–13 |year= 1967 |pmid= 6024251 |doi= 10.1001/archneur.1967.00470190005001}} |
||
*{{cite journal | author=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides |journal=Gene |volume=138 |issue= 1–2 |pages= 171–4 |year= 1994 |pmid= 8125298 |doi=10.1016/0378-1119(94)90802-8 }} |
*{{cite journal | author=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides |journal=Gene |volume=138 |issue= 1–2 |pages= 171–4 |year= 1994 |pmid= 8125298 |doi=10.1016/0378-1119(94)90802-8 }} |
||
*{{cite journal | author=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, ''et al.'' |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library |journal=Gene |volume=200 |issue= 1–2 |pages= 149–56 |year= 1997 |pmid= 9373149 |doi=10.1016/S0378-1119(97)00411-3 }} |
*{{cite journal | author=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, ''et al.'' |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library |journal=Gene |volume=200 |issue= 1–2 |pages= 149–56 |year= 1997 |pmid= 9373149 |doi=10.1016/S0378-1119(97)00411-3 }} |
||
Revision as of 09:40, 16 August 2014
Template:PBB Maspardin is a protein that in humans is encoded by the SPG21 gene.[1][2][3]
Interactions
SPG21 has been shown to interact with CD4.[1]
References
- ^ a b Zeitlmann L, Sirim P, Kremmer E, Kolanus W (Mar 2001). "Cloning of ACP33 as a novel intracellular ligand of CD4". J Biol Chem. 276 (12): 9123–32. doi:10.1074/jbc.M009270200. PMID 11113139.
{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link) Cite error: The named reference "pmid11113139" was defined multiple times with different content (see the help page). - ^ Simpson MA, Cross H, Proukakis C, Pryde A, Hershberger R, Chatonnet A, Patton MA, Crosby AH (Oct 2003). "Maspardin Is Mutated in Mast Syndrome, a Complicated Form of Hereditary Spastic Paraplegia Associated with Dementia". Am J Hum Genet. 73 (5): 1147–56. doi:10.1086/379522. PMC 1180493. PMID 14564668.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Cite error: The named reference
entrezwas invoked but never defined (see the help page).
Further reading
 | This article on a gene on human chromosome 15 is a stub. You can help Wikipedia by expanding it. |